Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05001308
Other study ID # 8262
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date May 31, 2022

Study information

Verified date August 2021
Source University Hospital, Strasbourg, France
Contact Yvon RUCH, MD
Phone 33 3 69 55 12 19
Email yvon.ruch@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 31, 2022
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Major subject (=18 years old) - Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020 - Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research. Exclusion Criteria: - Subject having expressed opposition to participate in the study - Subject under guardianship, curatorship or safeguard of justice

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]
See also
  Status Clinical Trial Phase
Completed NCT02513576 - Physiotherapy Exercises in Patients With Sternal Instability After Cardiovascular Surgery N/A
Completed NCT00819286 - Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain N/A
Completed NCT00638014 - Rapid Sternal Closure System (TALON) Phase 4
Completed NCT04617353 - Combined Air-plasma Flow and Nitric Oxide Therapy in Cardiac Surgery N/A
Completed NCT02073760 - Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Not yet recruiting NCT01473979 - Delayed Primary Versus Late Secondary Wound Closure in Sternum Infections N/A
Recruiting NCT00876551 - Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks N/A
Completed NCT03961503 - Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients
Completed NCT04865003 - Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck Infections
Completed NCT03922191 - Post-Surgical Mediastinitis Within the CHU Brugmann Hospital
Terminated NCT00518687 - Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) Phase 2/Phase 3